ciprofloxacin has been researched along with oxyquinoline in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Abouelhassan, Y; Bai, F; Burch, GM; Garrison, AT; Huigens, RW; Jin, S; Kallifidas, D; Luesch, H; Nguyen, MT; Norwood, VM; Rolfe, M | 1 |
| Chellan, P; Land, KM; Sadler, PJ | 1 |
| Zhang, B | 1 |
| Alikeeva, GK; Avdeeva, LA; Brodov, LE; Golokhvastova, EL; Iakovleva, ON; Kaluzhina, TI; Mashilov, VP | 1 |
| Chopra, I; Mariner, KR; O'Neill, AJ; Ooi, N; Roebuck, D | 1 |
2 review(s) available for ciprofloxacin and oxyquinoline
| Article | Year |
|---|---|
Recent developments in drug discovery against the protozoal parasites Cryptosporidium and Toxoplasma.
Topics: Animals; Antiprotozoal Agents; Apoptosis; Cryptosporidiosis; Cryptosporidium; Diazepam Binding Inhibitor; Drug Discovery; Enzyme Inhibitors; Humans; Mice; Toxoplasma; Toxoplasmosis | 2017 |
Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles | 2019 |
4 other study(ies) available for ciprofloxacin and oxyquinoline
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Structure-Activity Relationships of a Diverse Class of Halogenated Phenazines That Targets Persistent, Antibiotic-Tolerant Bacterial Biofilms and Mycobacterium tuberculosis.
Topics: Biofilms; Carbon-13 Magnetic Resonance Spectroscopy; Drug Resistance, Bacterial; Drug Screening Assays, Antitumor; Halogens; HeLa Cells; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phenazines; Proton Magnetic Resonance Spectroscopy; Structure-Activity Relationship | 2016 |
[Experience in using new drug preparations for treating adult patients with acute intestinal infections].
Topics: Acute Disease; Adult; Anti-Infective Agents, Local; Carrier State; Ciprofloxacin; Drug Combinations; Drug Evaluation; Dysentery, Bacillary; Female; Humans; Hydroxyquinolines; Intestinal Diseases; Middle Aged; Oxyquinoline; Salmonella Food Poisoning; Shigella dysenteriae; Shigella flexneri; Shigella sonnei | 1990 |
Further characterization of Bacillus subtilis antibiotic biosensors and their use for antibacterial mode-of-action studies.
Topics: Amino Acyl-tRNA Synthetases; Anti-Bacterial Agents; Bacillus subtilis; Biosensing Techniques; Ciprofloxacin; Enzyme Inhibitors; Fatty Alcohols; Indoles; Mupirocin; Naphthoquinones; Oxyquinoline; Tetracyclines | 2011 |